Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Preferred Dividend Payments (2016 - 2020)

Historic Preferred Dividend Payments for Perspective Therapeutics (CATX) over the last 11 years, with Q3 2020 value amounting to $3000.0.

  • Perspective Therapeutics' Preferred Dividend Payments changed 0.0% to $3000.0 in Q3 2020 from the same period last year, while for Jun 2021 it was $3000.0, marking a year-over-year decrease of 7272.73%. This contributed to the annual value of $3000.0 for FY2021, which is 7272.73% down from last year.
  • Per Perspective Therapeutics' latest filing, its Preferred Dividend Payments stood at $3000.0 for Q3 2020, which was down 0.0% from $3000.0 recorded in Q2 2020.
  • In the past 5 years, Perspective Therapeutics' Preferred Dividend Payments ranged from a high of $3000.0 in Q1 2016 and a low of $2000.0 during Q4 2016
  • Its 5-year average for Preferred Dividend Payments is $2842.1, with a median of $3000.0 in 2016.
  • Per our database at Business Quant, Perspective Therapeutics' Preferred Dividend Payments tumbled by 3333.33% in 2016 and then skyrocketed by 5000.0% in 2017.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Preferred Dividend Payments stood at $2000.0 in 2016, then skyrocketed by 50.0% to $3000.0 in 2017, then crashed by 33.33% to $2000.0 in 2018, then changed by 0.0% to $2000.0 in 2019, then skyrocketed by 50.0% to $3000.0 in 2020.
  • Its Preferred Dividend Payments was $3000.0 in Q3 2020, compared to $3000.0 in Q2 2020 and $3000.0 in Q1 2020.